[KTTA] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -93.49%
YoY- 107.45%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 241 219 14 14 15 0 0 -
PBT -5,118 -4,586 -2,658 -1,574 630 -1,526 -728 265.68%
Tax -1,215 671 -843 -1,616 0 0 0 -
NP -3,902 -5,257 -1,815 41 630 -1,526 -728 205.33%
Tax Rate - - - - -0.00% - - -
Total Cost 4,143 5,475 1,829 -28 -615 1,526 728 217.74%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -1,621.19 -2,404.65 -13,364.21 302.78 4,183.53 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -3.00 -0.20 -0.08 0.00 0.06 -0.17 -0.07 1116.30%
EPS Diluted -3.00 -0.20 -0.08 0.00 0.06 -0.17 -0.07 1116.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.